• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者的口腔状态与唾液皮质醇

Oral State and Salivary Cortisol in Multiple Sclerosis Patients.

作者信息

Kapel-Reguła Aleksandra, Chojdak-Łukasiewicz Justyna, Rybińska Anna, Duś-Ilnicka Irena, Radwan-Oczko Małgorzata

机构信息

Private Dental Practice AL-DENTA, 48-303 Nysa, Poland.

Department of Neurology, Faculty of Medicine, Wroclaw Medical University, 55-556 Wroclaw, Poland.

出版信息

Biomedicines. 2024 Oct 8;12(10):2277. doi: 10.3390/biomedicines12102277.

DOI:10.3390/biomedicines12102277
PMID:39457590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11504177/
Abstract

MS patients experience gradual and progressive functional limitation, bulbar symptoms, cognitive dysfunction, and psychiatric disorders that can impinge on oral status. This study aimed to investigate the oral state, oral hygiene habits, and salivary cortisol levels in patients with relapsing-remitting multiple sclerosis (RRMS) compared to healthy controls. It also evaluated systemic parameters: disease duration, type of Disease Modifying Therapy (DMT), disability score, professional activity, and smoking in the study group. This study included 101 patients (71 women and 30 men, aged 16-71 years) and 51 healthy volunteers (36 women and 15 men, aged 28-82 years). The oral examination assessed the number of teeth, type and number of dental fillings and prosthetic restoration, oral hygiene state, and salivary cortisol. It was found that MS patients had significantly more professional activity, swallowing problems, pronunciation issues, dry mouth, and taste disturbances than the control group. They brushed their teeth twice daily significantly less often. The API was higher, while the SBI was lower in MS patients. Disease duration positively correlated with age and number of missing teeth. The Expanded Disability Status Scale positively correlated with age, disease duration, number of missing teeth, number of composite fillings, and right and left-hand Nine Hole Peg test scores, and negatively correlated with the Sulcus Bleeding Index. Salivary cortisol levels did not differ between groups and correlated only with the disability scale. MS patients require ongoing dental care and preventive measures to manage both general and oral health symptoms effectively.

摘要

多发性硬化症(MS)患者会经历逐渐且进行性的功能受限、延髓症状、认知功能障碍以及可能影响口腔状况的精神障碍。本研究旨在调查复发缓解型多发性硬化症(RRMS)患者与健康对照者相比的口腔状况、口腔卫生习惯和唾液皮质醇水平。研究还评估了全身参数:病程、疾病修正治疗(DMT)类型、残疾评分、职业活动以及研究组中的吸烟情况。本研究纳入了101例患者(71名女性和30名男性,年龄16 - 71岁)和51名健康志愿者(36名女性和15名男性,年龄28 - 82岁)。口腔检查评估了牙齿数量、补牙和修复体的类型及数量、口腔卫生状况和唾液皮质醇。结果发现,与对照组相比,MS患者的职业活动更多,存在吞咽问题、发音问题、口干和味觉障碍。他们每天刷牙两次的频率明显更低。MS患者的菌斑指数(API)更高,而龈沟出血指数(SBI)更低。病程与年龄和缺失牙数量呈正相关。扩展残疾状态量表与年龄、病程、缺失牙数量、复合补牙数量以及左右手九点指鼻试验得分呈正相关,与龈沟出血指数呈负相关。两组间唾液皮质醇水平无差异,且仅与残疾量表相关。MS患者需要持续的牙科护理和预防措施,以有效管理全身和口腔健康症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ee/11504177/1396d7c1c713/biomedicines-12-02277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ee/11504177/1396d7c1c713/biomedicines-12-02277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ee/11504177/1396d7c1c713/biomedicines-12-02277-g001.jpg

相似文献

1
Oral State and Salivary Cortisol in Multiple Sclerosis Patients.多发性硬化症患者的口腔状态与唾液皮质醇
Biomedicines. 2024 Oct 8;12(10):2277. doi: 10.3390/biomedicines12102277.
2
Multiple sclerosis: oral health, behaviours and limitations of daily oral hygiene - a questionnaire study.多发性硬化症:口腔健康、行为及日常口腔卫生的限制——一项问卷调查研究
Neurol Neurochir Pol. 2019;53(4):271-276. doi: 10.5603/PJNNS.a2019.0033. Epub 2019 Aug 23.
3
Effectiveness of professional oral health care intervention on the oral health of residents with dementia in residential aged care facilities: a systematic review protocol.专业口腔保健干预对老年护理机构中痴呆症居民口腔健康的有效性:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):110-22. doi: 10.11124/jbisrir-2015-2330.
4
Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis.与其他用于治疗多发性硬化症的疾病修正疗法相比,奥瑞珠单抗相关的工作生产力结果。
Neurol Ther. 2021 Jun;10(1):183-196. doi: 10.1007/s40120-020-00224-1. Epub 2020 Nov 26.
5
Cortisol awakening response is linked to disease course and progression in multiple sclerosis.皮质醇觉醒反应与多发性硬化症的病程和进展有关。
PLoS One. 2013 Apr 16;8(4):e60647. doi: 10.1371/journal.pone.0060647. Print 2013.
6
Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.米托蒽醌治疗复发缓解型和快速进展型多发性硬化症:米托蒽醌治疗后十年的临床结果
Mult Scler Relat Disord. 2020 Sep;44:102330. doi: 10.1016/j.msard.2020.102330. Epub 2020 Jun 23.
7
Rituximab for relapsing-remitting multiple sclerosis.利妥昔单抗用于复发缓解型多发性硬化症。
Cochrane Database Syst Rev. 2013 Dec 6;2013(12):CD009130. doi: 10.1002/14651858.CD009130.pub3.
8
Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability.功能和结构连接基础认知表现复发缓解多发性硬化轻度残疾。
Neuroimage Clin. 2020;25:102177. doi: 10.1016/j.nicl.2020.102177. Epub 2020 Jan 12.
9
Teriflunomide for multiple sclerosis.特立氟胺用于治疗多发性硬化症。
Cochrane Database Syst Rev. 2012 Dec 12;12:CD009882. doi: 10.1002/14651858.CD009882.pub2.
10
Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.使用多水平模型对复发缓解型多发性硬化症的疾病进展进行建模,该模型应用于来自两个自然史队列和一个治疗队列的纵向数据。
Health Technol Assess. 2016 Oct;20(81):1-48. doi: 10.3310/hta20810.

引用本文的文献

1
Axis I of DC/TMD in Diagnosis of Temporomandibular Disorders in People with Multiple Sclerosis-Preliminary Reports.用于诊断多发性硬化症患者颞下颌关节紊乱病的DC/TMD轴I——初步报告
J Clin Med. 2025 Jun 18;14(12):4338. doi: 10.3390/jcm14124338.
2
Oral Manifestations of Multiple Sclerosis: A Systematic Review.多发性硬化的口腔表现:一项系统评价
J Clin Med. 2025 Apr 24;14(9):2944. doi: 10.3390/jcm14092944.
3
Evaluation of salivary nitric oxide levels and anxiety in multiple sclerosis patients, with and without Xerostomia: correlation with clinical variables.

本文引用的文献

1
Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic Approaches.多发性硬化症的发病机制和靶向治疗方法的更新。
Curr Allergy Asthma Rep. 2023 Sep;23(9):481-496. doi: 10.1007/s11882-023-01102-0. Epub 2023 Jul 4.
2
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis.治疗初发缓解型多发性硬化症的高效疗法。
CNS Drugs. 2022 Dec;36(12):1285-1299. doi: 10.1007/s40263-022-00965-7. Epub 2022 Nov 9.
3
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management.
评估有无口干症的多发性硬化症患者的唾液一氧化氮水平和焦虑情况:与临床变量的相关性
BMC Oral Health. 2025 Apr 8;25(1):507. doi: 10.1186/s12903-025-05878-7.
单克隆抗体在复发性多发性硬化症治疗中的应用:重点关注妊娠、疫苗接种和风险管理的概述。
Neurotherapeutics. 2022 Apr;19(3):753-773. doi: 10.1007/s13311-022-01224-9. Epub 2022 Apr 4.
4
Cognitive function and oral health in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症患者的认知功能与口腔健康。
Clin Oral Investig. 2022 Mar;26(3):2899-2907. doi: 10.1007/s00784-021-04272-1. Epub 2021 Nov 13.
5
Update on treatment in multiple sclerosis.多发性硬化症的治疗进展。
Presse Med. 2021 Jun;50(2):104068. doi: 10.1016/j.lpm.2021.104068. Epub 2021 May 24.
6
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.全球多发性硬化症患病率上升:第三版多发性硬化症图谱的见解。
Mult Scler. 2020 Dec;26(14):1816-1821. doi: 10.1177/1352458520970841. Epub 2020 Nov 11.
7
Clinical comparison of an electric-powered ionic toothbrush and a manual toothbrush in plaque reduction: A randomized clinical trial.电动离子牙刷和手动牙刷在减少菌斑方面的临床比较:一项随机临床试验。
Int J Dent Hyg. 2021 Feb;19(1):93-98. doi: 10.1111/idh.12475. Epub 2020 Nov 1.
8
Interferons in the Treatment of Multiple Sclerosis: A Clinical Efficacy, Safety, and Tolerability Update.干扰素治疗多发性硬化症:临床疗效、安全性及耐受性最新进展
Int J MS Care. 2020 Jul-Aug;22(4):165-172. doi: 10.7224/1537-2073.2018-063. Epub 2019 Oct 30.
9
Relation between cognitive fatigue and circadian or stress related cortisol levels in MS patients.多发性硬化症患者认知疲劳与昼夜节律或应激相关皮质醇水平之间的关系。
Mult Scler Relat Disord. 2020 Oct;45:102440. doi: 10.1016/j.msard.2020.102440. Epub 2020 Aug 3.
10
Nine Hole Peg Test asymmetry in refining upper limb assessment in multiple sclerosis.九孔插板试验在改善多发性硬化症上肢评估中的不对称性
Mult Scler Relat Disord. 2020 Oct;45:102422. doi: 10.1016/j.msard.2020.102422. Epub 2020 Jul 24.